COMMUNIQUÉS West-GlobeNewswire

-
Athenex to Present at UBS Global Healthcare Conference
21/05/2018 - 14:00 -
PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the American Association of Critical-Care Nurses Exposition May 22-24
21/05/2018 - 14:00 -
Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration
21/05/2018 - 14:00 -
CLS Holdings USA Expects to Close its Acquisition of Oasis Cannabis by the End of the Second Quarter
21/05/2018 - 14:00 -
Inovio Opens Phase 2 Trial for VGX-3100 in Third Indication To Treat HPV – The No. 1 Sexually Transmitted Disease
21/05/2018 - 14:00 -
Akari Therapeutics Receives Notice Related to Delay in 20-F Filing
21/05/2018 - 14:00 -
Cidara Therapeutics Announces Offering of Common Stock and Warrants
21/05/2018 - 13:30 -
MyoKardia Announces Design of Phase 3 EXPLORER-HCM Study Evaluating Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy
21/05/2018 - 13:30 -
Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia
21/05/2018 - 13:30 -
Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study
21/05/2018 - 13:01 -
AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board
21/05/2018 - 13:01 -
Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
21/05/2018 - 13:00 -
Microbot Medical Successfully Completes Pre-Clinical Study for its Self-Cleaning Shunt
21/05/2018 - 13:00 -
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
21/05/2018 - 12:30 -
BriaCell’s Lead Product Candidate’s Novel Mechanism of Action Published in a Reputable Immunology Journal
21/05/2018 - 12:30 -
Tetraphase Pharmaceuticals to Present Eravacycline and TP-6076 Data at ASM Microbe 2018
21/05/2018 - 12:00 -
Terveystalo Plc: Managers' Transactions
21/05/2018 - 11:36 -
NovoEight® maintains potency when stored at 40ºC offering people with haemophilia A increased flexibility in their daily lives
21/05/2018 - 10:01 -
Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.
21/05/2018 - 08:30
Pages